6533b830fe1ef96bd1296884
RESEARCH PRODUCT
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women
Octavio BurguésM. I. MartínezEduardo TormoGloria RibasSara S. OltraMarta NacherAna LluchElisa AlonsoMaria Peña-chiletIsabel ChirivellaBegoña BermejoMarta AlbanellAna FerrerCristina HernandoJuan Miguel CejalvoPilar Erolessubject
0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyDose dependencelcsh:RC254-282ArticleLMK-23503 medical and health sciences0302 clinical medicineBreast cancerbreast cancerOlder patientsInternal medicinemedicineskin and connective tissue diseasesPathologicalHDAC5 inhibitorsHistone deacetylase 5young womenbusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.disease030104 developmental biologyOncologyApoptosisCell culture030220 oncology & carcinogenesishistone deacetylaseHistone deacetylasebusinessdescription
Background: Breast cancer in very young women (BCVY) defined as <
year | journal | country | edition | language |
---|---|---|---|---|
2020-02-10 |